Quadrant Growth Fund 2 Invests in Evolution Surgical

August 26, 2024

Quadrant Private Equity, via its $530 million Growth Fund 2, has agreed to invest in Evolution Surgical, an Australian designer and manufacturer of spinal implants and biologics. The firm will partner with Evolution CEO Jack Lancaster and management to support the company’s product development and commercial expansion.

Buyers
Quadrant Private Equity (Growth Fund 2)
Targets
Evolution Surgical
Industry
Medical Devices
Location
New South Wales, Australia
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.